United States · Funded startup
5 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$106Mraised across 5 rounds since 2004, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $15M sold, first sale Nov 2013
No investor was named in the report.
Reported by sec.govSEC filing: $15M sold, first sale Nov 2013
No investor was named in the report.
Reported by sec.govSEC filing: $19M sold, first sale Jul 2012
No investor was named in the report.
From a historical funding recordSEC filing: $31M sold, first sale Oct 2010
New Enterprise Associates
Canaan
Frazier Healthcare Partners
Prospect Venture Partners
Radius VenturesFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
New Enterprise AssociatesCanaan
SVB CapitalFrazier Healthcare PartnersProspect Venture Partners
Oxford Finance LLCRadius VenturesCHL Medical Partners
MidCap FinancialMissing a round, or an investor who was in one? Tell us.
Amicus Therapeutics's investors include New Enterprise Associates, Canaan, SVB Capital, Frazier Healthcare Partners and Prospect Venture Partners, and 4 more on record.
Amicus Therapeutics has raised $106M across 5 rounds since 2004.
Amicus Therapeutics's most recent round was a Debt of $10M in Dec 2013.
Amicus Therapeutics's largest round on record is $31M (Venture), in Nov 2010.
Amicus Therapeutics's first round on record, in May 2004, was backed by New Enterprise Associates, Canaan and Frazier Healthcare Partners and 3 others.
Amicus Therapeutics's latest named round is a Debt, in Dec 2013.
Amicus Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·